These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
166 related articles for article (PubMed ID: 8703389)
1. A novel organ preservation protocol for advanced carcinoma of the larynx and pharynx. Robbins KT; Fontanesi J; Wong FS; Vicario D; Seagren S; Kumar P; Weisman R; Pellitteri P; Thomas JR; Flick P; Palmer R; Weir A; Kerber C; Murry T; Ferguson R; Los G; Orloff L; Howell SB Arch Otolaryngol Head Neck Surg; 1996 Aug; 122(8):853-7. PubMed ID: 8703389 [TBL] [Abstract][Full Text] [Related]
2. Targeted chemoradiation for advanced head and neck cancer: analysis of 213 patients. Robbins KT; Kumar P; Wong FS; Hartsell WF; Flick P; Palmer R; Weir AB; Neill HB; Murry T; Ferguson R; Hanchett C; Vieira F; Bush A; Howell SB Head Neck; 2000 Oct; 22(7):687-93. PubMed ID: 11002324 [TBL] [Abstract][Full Text] [Related]
3. Ototoxic effects of supradose cisplatin with sodium thiosulfate neutralization in patients with head and neck cancer. Madasu R; Ruckenstein MJ; Leake F; Steere E; Robbins KT Arch Otolaryngol Head Neck Surg; 1997 Sep; 123(9):978-81. PubMed ID: 9305250 [TBL] [Abstract][Full Text] [Related]
4. Selective (intra-arterial), rapid infusion chemo-radiotherapy to preserve the larynx in advanced laryngeal carcinoma: preliminary results. Nakashima T; Mihoki T; Ono T; Umeno H; Tanaka N J Laryngol Otol Suppl; 2009; (31):30-4. PubMed ID: 19460201 [TBL] [Abstract][Full Text] [Related]
5. Bone or cartilage invasion by advanced head and neck cancer: intra-arterial supradose cisplatin chemotherapy and concomitant radiotherapy for organ preservation. Samant S; Robbins KT; Kumar P; Ma JZ; Vieira F; Hanchett C Arch Otolaryngol Head Neck Surg; 2001 Dec; 127(12):1451-6. PubMed ID: 11735813 [TBL] [Abstract][Full Text] [Related]
6. Phase II trial: concurrent radio-chemotherapy with weekly docetaxel for advanced squamous cell carcinoma of head and neck. Biete Solà A; Marruecos Querol J; Calvo Manuel FA; Verger Fransoy E; Rovirosa Casino A; Grau de Castro JJ; de Las Heras González M; Ramos Aguerri A; Palacios Eito A; Veiras Candal C; Solano López MV Clin Transl Oncol; 2007 Apr; 9(4):244-50. PubMed ID: 17462977 [TBL] [Abstract][Full Text] [Related]
7. Efficacy of targeted supradose cisplatin and concomitant radiation therapy for advanced head and neck cancer: the Memphis experience. Robbins KT; Kumar P; Regine WF; Wong FS; Weir AB; Flick P; Kun LE; Palmer R; Murry T; Fontanesi J; Ferguson R; Thomas R; Hartsell W; Paig CU; Salazar G; Norfleet L; Hanchett CB; Harrington V; Niell HB Int J Radiat Oncol Biol Phys; 1997 May; 38(2):263-71. PubMed ID: 9226312 [TBL] [Abstract][Full Text] [Related]
8. A targeted supradose cisplatin chemoradiation protocol for advanced head and neck cancer. Robbins KT; Vicario D; Seagren S; Weisman R; Pellitteri P; Kerber C; Orloff L; Los G; Howell SB Am J Surg; 1994 Nov; 168(5):419-22. PubMed ID: 7977964 [TBL] [Abstract][Full Text] [Related]
9. Concomitant radiation therapy and targeted cisplatin chemotherapy for the treatment of advanced pyriform sinus carcinoma: disease control and preservation of organ function. Samant S; Kumar P; Wan J; Hanchett C; Vieira F; Murry T; Wong FS; Robbins KT Head Neck; 1999 Oct; 21(7):595-601. PubMed ID: 10487945 [TBL] [Abstract][Full Text] [Related]
10. High-dose cisplatin as neoadjuvant organ-preserving chemotherapy for squamous cell carcinoma of the larynx. Lacava JA; Ferreyra R; Leone BA; Losada C; Elem YL; Vallejo CT Cancer J Sci Am; 1996; 2(1):46-51. PubMed ID: 9166498 [TBL] [Abstract][Full Text] [Related]
11. Role of concomitant chemoradiation in locally advanced head and neck cancers. Lasrado S; Moras K; Pinto GJ; Bhat M; Hegde S; Sathian B; Luis NA Asian Pac J Cancer Prev; 2014; 15(10):4147-52. PubMed ID: 24935361 [TBL] [Abstract][Full Text] [Related]
12. Postoperative radiation of free jejunal autografts in patients with advanced cancer of the head and neck. Cole CJ; Garden AS; Frankenthaler RA; Reece GP; Morrison WH; Ang KK; Peters LJ Cancer; 1995 May; 75(9):2356-60. PubMed ID: 7712448 [TBL] [Abstract][Full Text] [Related]
13. Incidence and costs of treatment-related complications among patients with advanced squamous cell carcinoma of the head and neck. Lang K; Sussman M; Friedman M; Su J; Kan HJ; Mauro D; Tafesse E; Menzin J Arch Otolaryngol Head Neck Surg; 2009 Jun; 135(6):582-8. PubMed ID: 19528407 [TBL] [Abstract][Full Text] [Related]
14. Complications associated with selective high-dose intraarterial cisplatin and concomitant radiation therapy for advanced head and neck cancer. Gemmete JJ J Vasc Interv Radiol; 2003 Jun; 14(6):743-8. PubMed ID: 12817041 [TBL] [Abstract][Full Text] [Related]
15. [Induction chemotherapy using vinorelbine, cisplatin, and UFT in advanced pharyngeo-laryngeal carcinomas: results of a phase II study]. Rubio Suárez A; Teigeiro Núñez V; Gallo Terán J; Señaris González B; Mesuro Domínguez N Acta Otorrinolaringol Esp; 2003 Dec; 54(10):697-703. PubMed ID: 15164709 [TBL] [Abstract][Full Text] [Related]
16. High-dose intra-arterial cisplatin therapy followed by radiation therapy for advanced squamous cell carcinoma of the head and neck. Wilson WR; Siegel RS; Harisiadis LA; Davis DO; Nguyen HH; Bank WO Arch Otolaryngol Head Neck Surg; 2001 Jul; 127(7):809-12. PubMed ID: 11448355 [TBL] [Abstract][Full Text] [Related]
17. The predictive value of tumor regression rates during chemoradiation therapy in patients with advanced head and neck squamous cell carcinoma. Denys D; Kumar P; Wong FS; Newman LA; Robbins KT Am J Surg; 1997 Nov; 174(5):561-4. PubMed ID: 9374238 [TBL] [Abstract][Full Text] [Related]
18. Split hyperfractionated accelerated radiation therapy and concomitant cisplatin for locally advanced head and neck carcinomas: a preliminary report. Arias F; Domínguez MA; Illarramendi JJ; Martínez E; Tejedor M; Domínguez S; Dueñas M; Villafranca E; Elcarte F; Miquéliz S Int J Radiat Oncol Biol Phys; 1995 Oct; 33(3):675-82. PubMed ID: 7558958 [TBL] [Abstract][Full Text] [Related]
19. Rapidly alternating chemotherapy and hyperfractionated radiotherapy in the management of locally advanced head and neck carcinoma: four-year results of a phase I/II study. Leyvraz S; Pasche P; Bauer J; Bernasconi S; Monnier P J Clin Oncol; 1994 Sep; 12(9):1876-85. PubMed ID: 8083711 [TBL] [Abstract][Full Text] [Related]
20. Superselective intra-arterial chemoradiation therapy for functional laryngeal preservation in advanced squamous cell carcinoma of the glottic larynx. Furusaka T; Matsuda A; Tanaka A; Matsuda H; Ikeda M Acta Otolaryngol; 2013 Jun; 133(6):633-40. PubMed ID: 23394224 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]